AstraZeneca ordered an online platform for medical consultations from a Russian company

At the end of April 2021, it became known about the conclusion of a contract between the British pharmaceutical giant AstraZeneca and the Russian technology company Unim. We are talking about the development of an online platform for educational consultations of doctors specializing in oncology.

According to Vedomosti, citing company representatives, UNIM is ordering AstraZeneca to adapt its Digital Pathology software. On this platform, AstraZeneca will launch a large-scale educational project in 2021 aimed at raising standards for the diagnosis of lung cancer. In the future, this experience can be extended to other areas of therapy, the publication was told in AstraZeneca.

AstraZeneca ordered an online platform for physician consultations from Unim

The launch of the 5-month project is scheduled for June 2021. During its implementation, 400 pathomorphologists are expected to undergo training on the platform, mainly from Asian countries (Singapore, South Korea, Taiwan), the Middle East (Egypt, Saudi Arabia, the UAE) and Latin America (Brazil, Mexico, Argentina).

The project is relevant for all countries of the world, since lung cancer occupies a leading position among the causes of death among cancer, UNIM founder and co-owner Alexei Remez told the newspaper. According to him, the cost of the contract with AstraZeneca amounted to several tens of thousands of dollars.

Boris Zingerman, director of the National Medical Knowledge Base Association, believes that the joint project between AstraZeneca and UNIM opens up new opportunities for the entire field of telemedicine. According to him, the development of UNIM allows you to digitize histological drugs, upload their digital images to the platform, discuss and describe them from anywhere in the world, attracting various specialists. This opens up new opportunities for all doctors involved in the treatment of oncology, he is sure.^[1]

Notes